Lab study explores cannabis Compounds' power over immune disorders

NCT ID NCT06842316

First seen Jan 05, 2026 · Last updated May 05, 2026 · Updated 15 times

Summary

This study looks at how natural cannabis compounds (phytocannabinoids) affect immune cells from people with chronic inflammatory diseases like rheumatoid arthritis, lupus, and Crohn's disease. Researchers will collect blood from 100 patients and expose their cells to different cannabis extracts in a lab. The goal is to see which compounds best reduce inflammation and change immune cell activity, without giving any treatment to patients directly.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SJOGREN'S SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU d'ORLEANS

    RECRUITING

    Orléans, 45067, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.